Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Desensitization in Kidney Allograft Recipients Before Transplantation Using Daratumumab

NCT04204980 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04204980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04204980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Desensitization in Kidney Allograft Recipients Before Transplantation Using Daratumumab
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 1/2
Overall status
Completed
Start date
February 18, 2020
Completion date
June 1, 2023
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allosensitization, antibody-mediated rejection, kidney transplant rejection